Trond Williksen buys 180,000 shares in Benchmark

editorial staff

Chief Executive Officer has bought in.

In a post in the London Stock Exchange, British fish health company Benchmark writes that has been informed that new boss Trond Williksen has purchased a total of 180,000 ordinary shares of 0.1 pence each in Benchmark at a price of 46 pence per share on 2nd and 3rd September.

Following this purchase, Trond Williksen’s total beneficial interest in the company is 180,000 ordinary shares, representing approximately 0.03 per cent of the Benchmark’s issued share capital.

Last week, SalmonBusiness reported that CEO Trond Williksen was aiming at ambitious cost-cutting with the completion of its disposal programme generating up to GBP 44 million.